Close
Back to AXON Stock Lookup

Axon (AXON) – Major News

Nov 7, 2023 04:03 PM Axon (AXON) Tops Q3 EPS by 26c; raises FY revenue outlook
Aug 8, 2023 04:04 PM Axon (AXON) Tops Q2 EPS by 49c; raises guidance
May 9, 2023 04:02 PM Axon (AXON) Tops Q1 EPS by 34c; Raises Outlook
Feb 28, 2023 04:09 PM Axon (AXON) Tops Q4 EPS by 19c, Offers Guidance
Nov 8, 2022 04:04 PM Axon (AXON) Tops Q3 EPS by 11c; Offers Guidance
Aug 9, 2022 04:03 PM Axon (AXON) Tops Q2 EPS by 5c, Offers Guidance
May 10, 2022 04:03 PM Axon (AXON) Tops Q1 EPS by 15c
Feb 24, 2022 04:06 PM Axon (AXON) Tops Q4 EPS by 28c
Nov 15, 2021 05:31 PM Axon (AXON) Surges Higher on Q3 Beat
Aug 5, 2021 04:05 PM Axon (AXON) Tops Q2 EPS by 16c
May 6, 2021 04:04 PM Axon (AXON) Tops Q1 EPS by 10c; Raises Outlook
Feb 25, 2021 04:03 PM Axovant Sciences (AXON) Tops Q4 EPS by 4c; Raises Outlook
Jun 6, 2018 07:13 AM Oxford BioMedica, Axovant Sciences (AXON) Enter $842.5M Agreement to Commercialize OXB-102
Feb 12, 2018 07:04 AM Axovant Sciences (AXON) CEO, COO and Several Directors Resign; Pavan Cheruvu Joins as CEO
Sep 26, 2017 07:02 AM Axovant (AXON) Says its Intepirdine Phase 3 MINDSET Trial in AD Did Not Meet its co-Primary Efficacy Endpoints
Jun 13, 2017 07:09 AM Axovant Sciences (AXON) Reports Q4 Loss of $0.53/Share
Apr 10, 2017 08:16 AM Axovant Sciences (AXON) Names David Hung as CEO
Aug 16, 2016 07:24 AM Axovant Sciences (AXON) Misses Q1 EPS by 2c; Enters Licensing Agreement with Qaam Pharma
Feb 9, 2016 05:02 PM Axovant Sciences Ltd. (AXON) Reports Q3 Loss Per Share of 64c
Nov 2, 2015 04:38 PM Axovant Sciences Ltd. (AXON) Tops Q2 EPS by 12c
Aug 11, 2015 04:24 PM Axovant Sciences Ltd. (AXON) Reports Q1 Loss of $0.35, Names CFO
Jul 22, 2015 12:02 PM Axovant Sciences Ltd. (AXON) Announces Statistically Significant Data from RVT-101 Phase 2 in AD
Jun 11, 2015 09:48 AM Axovant Sciences (AXON) IPO Opens Up 40%
Jun 11, 2015 08:58 AM Axovant Sciences (AXON) IPO Prices at Top End of Range

Back to AXON Stock Lookup